Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

hemoregulatory peptide 5b

Known as: L-Lysine, N2-(N-(N-(N-(5-oxo-L-prolyl)-L-alpha-glutamyl)-L-alpha-aspartyl)-L-cysteinyl)-, SP1 pentapeptide, pyroglutamyl-glutamyl-aspartyl-cysteinyl-lysine 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1998
1998
We have previously shown that the pentapeptide pGlu-Glu-Asp-Cys-Lys (pEEDCK), which is associated with mature leukocytes… Expand
1997
1997
The hemoregulatory peptide, pGlu‐Glu‐Asp‐Cys‐Lys (pEEDCK or HP5b), has been shown to reversibly inhibit the proliferation of bone… Expand
1996
1996
G-proteins are essential in signal transduction pathways. A G-protein alpha subunit termed G alpha 16 was found to be exclusively… Expand
1994
1994
During the Third International Conference on Negative Control of Hematopoiesis (Paris, April 1993), a special session was devoted… Expand
1993
1993
Pre--CFU-S are characterized by their ability to generate spleen colony-forming cells (CFU-S) and by their ability to repopulate… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
1991
1991
We have previously shown that the synthetic peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK monomer) inhibits the cytostatic drug-induced… Expand
  • figure 2
  • figure 1
  • figure 4
  • figure 3
  • table 1
Review
1991
Review
1991
Cytostatic drug-induced haematopoietic damage is a major problem in tumour chemotherapy, due to the intensive proliferation of… Expand
1991
1991
Hematological damage is the main general problem in the therapy of malignant tumors with cytostatic substances. Part of the… Expand
1990
1990
The hemoregulatory peptide (pGlu-Glu-Asp-Cys-Lys, pEEDCK) is a potent inhibitor of stem cell recruitment, which is a major source… Expand
Review
1990
Review
1990
We have previously shown that the stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK monomer) leads to a good tolerance of… Expand